IQVIA Holdings Looking To Unlock Healthcare Innovation with High-Margin, Data-Driven Strategies; Will It Work? 

IQVIA’s recent financial performance and strategic direction provide a nuanced picture of its current position within the life sciences sector. In the first quarter of 2025, IQVIA reported strong financial results, achieving revenue growth at the high end of its expectations despite facing a challenging environment in Research & Development Solutions (R&DS). The company recorded total revenue of $3.829 billion, marking a 2.5% increase on a reported basis and a 3.5% rise at constant currency. Excluding COVID-related work, which significantly declined from the previous year, the adjusted growth was about 4.5%.